首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR IMPROVING, PREVENTING OR TREATING COGNITIVE DISORDERS COMPRISING EXTRACT OF LYCOPERSICON ESCULENTUM AS ACTIVE INGREDIENT

PHARMACEUTICAL COMPOSITION FOR IMPROVING, PREVENTING OR TREATING COGNITIVE DISORDERS COMPRISING EXTRACT OF LYCOPERSICON ESCULENTUM AS ACTIVE INGREDIENT

机译:用于改善,预防或治疗认知功能障碍的药物组合物,这些疾病包括作为活性成分的番茄红素提取物

摘要

The present invention relates to a pharmaceutical composition for improving, preventing or treating cognitive disorders comprising an extract of Lycopersicon esculentum as an active ingredient. The present invention provides a pharmaceutical composition and food composition for improving, preventing or treating cognitive disorders, a food composition for improving or preventing memory power or learning ability, a composition for inducing nerve growth factors and a method for differentiating nerve cells, which comprise an extract of Lycopersicon esculentum. The composition comprising an extract of Lycopersicon esculentum according to the present invention induces expression of blood brain barrier (BBB)-passing nerve growth factors, such as brain-derived neurotrophic factor (BDNF), fibroblast growth factor-2 (FGF-2) and Insulin-like growth factor-1 (IGF-1) expressed in skin cells.;COPYRIGHT KIPO 2017
机译:本发明涉及一种用于改善,预防或治疗认知障碍的药物组合物,该药物组合物包含食用番茄(Lycopersicon esculentum)的提取物作为活性成分。本发明提供了用于改善,预防或治疗认知障碍的药物组合物和食品组合物,用于改善或预防记忆力或学习能力的食品组合物,用于诱导神经生长因子的组合物和用于分化神经细胞的方法,包括番茄的提取物。根据本发明的包含番茄的提取物的组合物诱导通过血脑屏障(BBB)的神经生长因子的表达,所述神经生长因子例如是脑源性神经营养因子(BDNF),成纤维细胞生长因子-2(FGF-2)和皮肤细胞表达胰岛素样生长因子-1(IGF-1).; COPYRIGHT KIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号